Skip to contentC
CareDx, Inc.
C
CDNACareDx, Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$65.57M$65.57Mderived−20.4% vs Q4 2022 Net Income-$118.10M-$118.10MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CareDx, Inc. · CIK 1217234 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$122,632,000N/M Operating Cash Flowderived-$8,381,000N/M Margins · derivedOperating margin-187.0%−163.8 pt vs Q4 2022
Net margin-180.1%−157.9 pt vs Q4 2022
ended Dec 31, 2023 · filed Feb 28, 2024 · 59 d after period end